Yvonne Henskens

Associate professor

Dr Yvonne Henskens graduated with the specialisations in Biochemistry and Toxicology at Wageningen University. She worked on salivary cystatins in periodontal health and disease at the Department of Oral Biochemistry, Free University Amsterdam/Academic Centre for Dentistry (ACTA). After her PhD she started her specialisation for Clinical Chemistry at the Reinier de Graaf Gasthuis in Delft.

At this moment she is a clinical biochemist, working in laboratories for the past 15 years (Amsterdam Medical Centre and Maastricht UMC+). She has been responsible for the diagnostic tests concerning hematology, hemostasis and transfusion at Maastricht UMC+ since 2003.  She has special research interest in laboratory predictors of bleeding and in pre- and peri-operative management of coagulopathies: Active in the boards of the Dutch societies for hematologicallaboratories and clinical chemistry. Involved in training and education of medical and life sciences students, laboratory technicians and residents. Founder of a re-training programme on hemostasis and transfusion for technicians and clinical biochemists for the south-east part of the Netherlands.

Yvonne-henskens

Central Diagnostic Laboratory MUMC+
Department of Biochemistry
P. Debyelaan 25, 6229 HX Maastricht
Room number: 5.E2.001
T: +31(0)43 387 79 76

  • 2026
    • Nieuwenstein, T., Stoffer, I. P., Hellenbrand, D. L. S., Mathot, R. A. A., van Pelt, L. J., Pequeriaux, N. C. V., van de Kerkhof, D., Kuijper, P. H. M., Zant, J. C., Garnier, D. A. J., Schindhelm, R. K., Hamer, H. M., van Duijnhoven, H. L. P., Bosman, M. C. J., Jeninga, E. H., de Kok, J. B., Schellings, M. W. M., Waals-Prinzen, L., Rijpma, S. R., ... Stroobants, A. K. (2026). Reagent-specific anti-Xa DOAC safety cutoffs can be established using multiple LMWH-calibrated anti-Xa assays. Clinical Chemistry and Laboratory Medicine, 64(11), 2590-2601. https://doi.org/10.1515/cclm-2026-0026
    • de Jong, M. J., Hellenbrand, D. L. S., Braeken, D. C. W., ten Cate, H., Stroobants, A. K., Henskens, Y. M. C., Magdelijns, F. J. H., & Winckers, K. (2026). Detection of abnormally high DOAC plasma concentrations using PT/INR in three different reagents in frail older patients: the DOAC-FRAIL study. Thrombosis Update, 24, Article 100250. https://doi.org/10.1016/j.tru.2026.100250
    • Wang, S. J., Deneer, R., Schoenmakers, T., Mestrum, S. G. C., Henskens, Y. M. C., Bekers, O., Hopman, A. H. N., Ramaekers, F. C. S., & Leers, M. P. G. (2026). A Robust Computational Workflow Utilizing Generalized Least Squares (GLS) and Generalized Estimating Equations (GEE-GLM) for Longitudinal Flow Cytometry Maturation Data Analysis. Cytometry Part A, 109(9), 664-673. https://doi.org/10.1002/cyto.a.70061
    • Wang, S. J., van Meel, R. A. J. N., Mestrum, S. G. C., Habets, T. H. P. M., Hopman, A. H. N., Ramaekers, F. C. S., Henskens, Y. M. C., Bekers, O., & Leers, M. P. G. (2026). Functional Characterization of Myelodysplastic Syndrome by Multiparameter Flow Cytometry: The Clinical Synergy Between Ki-67 and Bcl-2 and Their Potential Role in Diagnostics and Personalized Therapy. Cancers, 18(16), Article 2648. https://doi.org/10.3390/cancers18162648
    • Mussert, C. M. A., Derikx, F., Monard, A. L. L., Brandt, B., Tegels, S. H. J., Merry, I., van Doorn, W. P. T. M., Nieuwenhuizen, L., Cnossen, M. H., Henskens, Y. M. C., Beckers, E. A. M., & Heubel-Moenen, F. C. J. I. (2026). Heavy menstrual bleeding in women with a bleeding disorder of unknown cause: a common symptom impacting daily life functioning. Research and practice in thrombosis and haemostasis, 10(6), Article 106950. https://doi.org/10.1016/j.rpth.2026.106950
    • Stroobants, A. K., Gottgens, E.-L., Henskens, Y. M. C., Jansen, J. H., Schols, S. E. M., & Rijpma, S. R. (2026). Monitoring Extended Half-Life Factor VIII and IX Concentrates: Performance in Routine Clotting-and Thrombin Generation Assays. Haemophilia, 32(4), 1002-1015. https://doi.org/10.1111/hae.70300
    • van Dam, A. D., Bioch, M. M., Jeninga, E. H., de Kok, J. B., Rijpma, S. R., Thelen, M. H. M., Henskens, Y. M. C., van Oerle, R. G. M., Stroobants, A. K., & Coagulation Section of the Dutch Foundation for Quality Assessment in Medical Laboratory Diagnostics (SKML) (2026). Pre-analytical storage and reagent-dependent sensitivity as sources of variability in prothrombin time and activated partial thromboplastin time measurements. Thrombosis Research, 263, Article 109771. https://doi.org/10.1016/j.thromres.2026.109771
    • Derikx, F., Merry, I., Willemsen, D., Beckers, E., Henskens, Y., & Heubel-Moenen, F. (2026). A Rare Combination of von Willebrand Disease Type 2A and 2M: Diagnostic and Therapeutic Challenges – A case report. Research and practice in thrombosis and haemostasis, 10(5), Article 106867. https://doi.org/10.1016/j.rpth.2026.106867
    • Franssen, I. S., de Jong, M. J., Visseren, L., Teerds, D., Hellenbrand, D., Henskens, Y., Spronk, H., Janssen, D. J. A., Braeken, D. C. W., van Kuijk, S. M. J., Winckers, K., & Magdelijns, F. J. H. (2026). The DOAC-FRAIL Study-Same Dose, Different Story: Prevalence of Deviant Direct Oral Anticoagulant Levels in Nursing Home Residents. Journal of the American Geriatrics Society. Advance online publication. https://doi.org/10.1111/jgs.70559
    • Schellens, J., Nagy, M., Hulshof, A. M., van Rosmalen, F., van Oerle, R., van Herpt, T. T. W., Alnima, T., Mulder, M. M. G., Hellenbrand, D., ten Cate, H., Driessen, R. G. H., Sels, J. W. E. M., van der Horst, I. C. C., Henskens, Y. M. C., van Bussel, B. C. T., Spronk, H. M. H., & Dutch Covid and Thrombosis Coalition (2026). Inhibition of inflammation reduces hypofibrinolysis in severe COVID-19: A nested case-control study within the MaastrICCht cohort. Thrombosis Research, 262, Article 109723. https://doi.org/10.1016/j.thromres.2026.109723